Skip to main content
Clinical Trials/NCT03521531
NCT03521531CompletedNot Applicable

Burden and Medical Care of Sarcoma in Germany: Nationwide Cohort Study Focusing on Modifiable Determinants of Patient-Reported Outcome Measures in Sarcoma Patients

Technische Universität Dresden1 site in 1 country1,309 target enrollmentStarted: September 30, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,309
Locations
1
Primary Endpoint
Quality of Life - EORTC QLQ-C30

Study Overview

Brief Summary

The main objective of the study is to assess the treatment situation of sarcoma patients in Germany and to investigate their potential influence on Quality of Life (and other Patient Reported Outcomes) of the affected persons. Impaired quality of life domains and factors associated with it are to be identified.

To this end, a national network of sarcoma treatment specialists and a structure for patient recruitment will be established. This care network is intended to reflect the current situation of the treatment of sarcoma patients in Germany.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with sarcoma diagnosis according to International Classification of Diseases for Oncology (ICD-O) and World Health Organisation (WHO) classification

Exclusion Criteria

  • not mentally able to fill out questionaires
  • not able to till out questionaires in German

Outcomes

Primary Outcomes

Quality of Life - EORTC QLQ-C30

Time Frame: 1 year

Measured with European Organization for Research and Treatment of Cancer Quality of Life Core Questionaire (EORTC QLQ-C30). The questionnaire consists of 30 questions assessing general quality of life issues of cancer patients. The EORTC QLQ-C30 includes 5 functional scales, measuring physical, role, emotional, cognitive, and social functioning, three multi-item symptom scales (fatigue, nausea/vomiting, and pain), and six single-item scales. High scores on the functional and global scales represent better quality of life. In contrast, high scores on the symptom scale indicate poor quality of life. Each instrument can reach values from 0-100.

Secondary Outcomes

  • Psychological Distress - PHQ-4(1 year)
  • Pain - Intensity (BPI)(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Markus Schuler

MD

Technische Universität Dresden

Study Sites (1)

Loading locations...

Similar Trials

Burden and Medical Care of Sarcoma in... | Clinical Trial